Paloma Partners Management Co - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 173 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Paloma Partners Management Co ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$451,000
-25.9%
10,839
-53.2%
0.01%
-33.3%
Q3 2020$609,000
+33.6%
23,159
-10.0%
0.02%
+114.3%
Q4 2019$456,000
+204.0%
25,742
+150.5%
0.01%
+40.0%
Q4 2018$150,000
-83.1%
10,277
-77.2%
0.01%
-64.3%
Q1 2018$885,000
+61.2%
45,130
+5.3%
0.01%
+133.3%
Q2 2017$549,000
+104.9%
42,849
+107.1%
0.01%
+100.0%
Q1 2017$268,000
+45.7%
20,687
+51.0%
0.00%
-25.0%
Q3 2015$184,000
+34.3%
13,700
-3.7%
0.00%
-33.3%
Q4 2014$137,00014,2260.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders